Financial results - NEXUS PHARMA S.R.L.

Financial Summary - Nexus Pharma S.r.l.
Unique identification code: 4751930
Registration number: J40/22883/1993
Nace: 4645
Sales - Ron
31.687
Net Profit - Ron
-6.379
Employees
1
Open Account
Company Nexus Pharma S.r.l. with Fiscal Code 4751930 recorded a turnover of 2020 of 31.687, with a net profit of -6.379 and having an average number of employees of 1. The company operates in the field of Comerţ cu ridicata al produselor cosmetice şi de parfumerie having the NACE code 4645.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Nexus Pharma S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 4.272.432 4.526.257 4.768.590 244.141 94.328 32.586 - - - -
Total Income - EUR 4.546.299 4.629.672 4.978.888 294.482 101.489 32.590 - - - -
Total Expenses - EUR 4.528.895 4.629.728 4.975.119 481.543 92.276 38.024 - - - -
Gross Profit/Loss - EUR 17.403 -56 3.770 -187.062 9.213 -5.435 - - - -
Net Profit/Loss - EUR 14.619 -751 824 -187.062 7.761 -6.560 - - - -
Employees 11 18 12 7 2 1 - - - -
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -64.8%, from 94.328 euro in the year 2019, to 32.586 euro in 2020. The Net Profit decreased by -7.614 euro, from 7.761 euro in 2019, to 0 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Nexus Pharma S.r.l.

Rating financiar

Financial Rating -
NEXUS PHARMA S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Nexus Pharma S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Nexus Pharma S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Nexus Pharma S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Nexus Pharma S.r.l. - CUI 4751930

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 36.913 54.293 73.382 6.437 827 1.567 - - - -
Current Assets 535.148 705.487 422.989 -11.302 -21.145 48.629 - - - -
Inventories 392.278 268.916 312.676 23.718 24.669 38.021 - - - -
Receivables 130.585 360.756 40.341 -45.986 -47.063 8.172 - - - -
Cash 12.285 75.815 69.972 10.967 1.249 2.435 - - - -
Shareholders Funds 22.083 21.107 21.574 -165.884 -154.891 -158.514 - - - -
Social Capital 227 225 221 217 232 227 - - - -
Debts 550.153 740.010 475.527 161.385 134.665 208.787 - - - -
Income in Advance 0 0 0 0 0 0 - - - -
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4645 - 4645"
CAEN Financial Year 4645
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 48.629 euro in 2020 which includes Inventories of 38.021 euro, Receivables of 8.172 euro and cash availability of 2.435 euro.
The company's Equity was valued at -158.514 euro, while total Liabilities amounted to 208.787 euro. Equity decreased by -6.560 euro, from -154.891 euro in 2019, to -158.514 in 2020.

Risk Reports Prices

Reviews - Nexus Pharma S.r.l.

Comments - Nexus Pharma S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.